Lin Shen

机构：Beijing Tongren Hospital, Fujian Medical University, Army Medical University, Harbin Medical University, Hangzhou Normal University, Peking University, Beijing Normal University, Wuqing District People's Hospital, Daqing City People's Hospital, Peking University Cancer Hospital, People’s Hospital of Linqing, Chinese University of Hong Kong, Shenzhen, First Affiliated Hospital of Fujian Medical University, Ministry of Education, Kementerian Pendidikan Malaysia · ORCID：0000-0003-1134-2922

发表论文 523 篇 · 总被引 19399 次 · h-index 57

代表论文

• Data from Allogeneic B7-H3–Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study (2026 · 被引 1)
• Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset (2026 · Oncogene)
• Tumor empowered binary macrophages regulate T cell interferon signaling to mediate immunotherapy resistance in gastric cancer (2026 · 中国科学通报：英文版)
• Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial (2026 · British Journal of Cancer)
• Table 4 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)
• Table 5 from BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings (2026)